NCT01392183
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying Pathologic Complete Response. Study availability and eligibility vary by location and protocol.
NCT01392183
NCT04271657
NCT03697928
NCT01216644
NCT00109525
NCT01580865
NCT00725283
NCT03601689
NCT03539965